Cancel-Tassin G - Search Results

1

Multiple loci identified in a genome-wide association study of prostate cancer.

Thomas G, Jacobs KB, Yeager M, Kraft P, Wacholder S, Orr N, Yu K, Chatterjee N, Welch R, Hutchinson A, Crenshaw A, Cancel-Tassin G, Staats BJ, Wang Z, Gonzalez-Bosquet J, Fang J, Deng X, Berndt SI, Calle EE, Feigelson HS, Thun MJ, Rodriguez C, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Giovannucci E, Willett WC, Cussenot O, Valeri A, Andriole GL, Crawford ED, Tucker M, Gerhard DS, Fraumeni JF Jr, Hoover R, Hayes RB, Hunter DJ, Chanock SJ. Thomas G, et al. Nat Genet. 2008 Mar;40(3):310-5. doi: 10.1038/ng.91. Epub 2008 Feb 10. Nat Genet. 2008. PMID: 18264096

2

PCAP is the major known prostate cancer predisposing locus in families from south and west Europe.

Cancel-Tassin G, Latil A, Valéri A, Mangin P, Fournier G, Berthon P, Cussenot O. Cancel-Tassin G, et al. Eur J Hum Genet. 2001 Feb;9(2):135-42. doi: 10.1038/sj.ejhg.5200592. Eur J Hum Genet. 2001. PMID: 11313747

3

No evidence of linkage to HPC20 on chromosome 20q13 in hereditary prostate cancer.

Cancel-Tassin G, Latil A, Valéri A, Guillaume E, Mangin P, Fournier G, Berthon P, Cussenot O. Cancel-Tassin G, et al. Int J Cancer. 2001 Aug 1;93(3):455-6. doi: 10.1002/ijc.1345. Int J Cancer. 2001. PMID: 11433415 No abstract available.

4

Targeted screening for prostate cancer in high risk families: early onset is a significant risk factor for disease in first degree relatives.

Valeri A, Cormier L, Moineau MP, Cancel-Tassin G, Azzouzi R, Doucet L, Baschet F, Cussenot I, L'Her J, Berthon P, Mangin P, Cussenot O, Morin JF, Fournier G. Valeri A, et al. J Urol. 2002 Aug;168(2):483-7. doi: 10.1016/s0022-5347(05)64663-0. J Urol. 2002. PMID: 12131293

5

A candidate gene approach within the susceptibility region PCaP on 1q42.2-43 excludes deleterious mutations of the PCTA-1 gene to be responsible for hereditary prostate cancer.

Maier C, Rösch K, Herkommer K, Bochum S, Cancel-Tassin G, Cussenot O, Häussler J, Assum G, Vogel W, Paiss T. Maier C, et al. Eur Urol. 2002 Sep;42(3):301-7. doi: 10.1016/s0302-2838(02)00280-4. Eur Urol. 2002. PMID: 12234517

6

Association study of polymorphisms in the human estrogen receptor alpha gene and prostate cancer risk.

Cancel-Tassin G, Latil A, Rousseau F, Mangin P, Bottius E, Escary JL, Berthon P, Cussenot O. Cancel-Tassin G, et al. Eur Urol. 2003 Oct;44(4):487-90. doi: 10.1016/s0302-2838(03)00319-1. Eur Urol. 2003. PMID: 14499686

7

[Genetic susceptibility to prostate cancer].

Cussenot O, Cancel-Tassin G. Cussenot O, et al. Med Sci (Paris). 2004 May;20(5):562-8. doi: 10.1051/medsci/2004205562. Med Sci (Paris). 2004. PMID: 15190476 Free article. Review. French.

8

Prostate cancer genetics.

Cancel-Tassin G, Cussenot O. Cancel-Tassin G, et al. Minerva Urol Nefrol. 2005 Dec;57(4):289-300. Minerva Urol Nefrol. 2005. PMID: 16247350 Review.

9

Genetic susceptibility to prostate cancer.

Cancel-Tassin G, Cussenot O. Cancel-Tassin G, et al. BJU Int. 2005 Dec;96(9):1380-5. doi: 10.1111/j.1464-410X.2005.05836.x. BJU Int. 2005. PMID: 16287462 Review. No abstract available.

10

Low penetrance genetic susceptibility to kidney cancer.

Thibault F, Cancel-Tassin G, Cussenot O. Thibault F, et al. BJU Int. 2006 Oct;98(4):735-8. doi: 10.1111/j.1464-410X.2006.06351.x. BJU Int. 2006. PMID: 16978268 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters